| Sharma H., Parekh S., Pujari P., Shewale S., Desai S., Bhatla N., Joshi S., Pimple S., Kawade A., Balasubramani L., Thomas A., Suri V., Lalwani S., Uday R., Kamath V., Mandal R., Rajeswar A., Peedicayil A., Poli U.R., Banerjee D., Sankaranarayanan R., Basu P., Muwonge R., Gairola S., Dogar V., Rao H., Shaligram U. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial. Lancet Oncol. 2023 Nov 7:S1470-2045(23)00480-1. PMID: 37949086 |
| M de Carvalho T., Man I., Georges D., Saraswati L.R., Bhandari P., Kataria I., Siddiqui M., Muwonge R., Lucas E., Sankaranarayanan R., Basu P., Berkhof J., Bogaards J.A., Baussano I. Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India. BMJ Glob Health. 2023 Nov;8(11):e012580. PMID: 37931940 |
| Bose S., Basu P., Mandal R., Chakrabarti J., Vernekar M., Banerjee D., Chatterjee P., Ray C. A Study of the Impact and Restitutive Efforts of Cervical Cancer Screening during the COVID-19 Pandemic in a Regionsl Cancer Centre in Eastern India. Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3495-3500. PMID: 37898855 |